An optically active or racemic .alpha.-hydroxyaldehyde represented by the general formula (2), ##STR1## wherein R.sub.1 represents a C.sub.6 -C.sub.14 aryl group, C.sub.1 -C.sub.10 alkyl group, C.sub.3 -C.sub.10 alkenyl group, C.sub.2 -C.sub.10 alkynyl group, C.sub.7 -C.sub.14 aralkyl group, or a group containing a functional group in the organic portion of said groups and R.sub.2 represents a C.sub.1 -C.sub.10 alkyl group, C.sub.2 -C.sub.10 alkenyl group, C.sub.2 -C.sub.10 alkynyl group, C.sub.7 -C.sub.14 aralkyl group, C.sub.6 -C.sub.14 aryl group, or a group containing a functional group in the organic portion of these groups, which is an important intermediate for preparation of pharmaceuticals and agricultural chemicals, and prepared by allowing an optically active or racemic compound represented by the general formula (1), ##STR2## (wherein A represents a C.sub.6 -C.sub.14 aryl group or a C.sub.1 -C.sub.4 alkyl or alkoxy group- or halogen-substituted C.sub.6 -C.sub.14 aryl group and R.sub.1 is as defined above) to react with a Grignard reagent, and thereafter hydrolyzing the reaction product.
This is a division of application Ser. No. 257,587 filed Apr. 27, 1981, now U.S. Pat. No. 4,383,122 which in turn is a division of application Ser. No. 89,356, filed Oct. 30, 1979, now U.S. Pat. No. 4,337,346.
Priority Data
Nov 02, 1978 [JP] 53-135511 Nov 06, 1978 [JP] 53-137147 Jun 04, 1979 [JP] 54-70365 Jun 04, 1979 [JP] 54-70366 Jun 04, 1979 [JP] 54-70367
Aerosol formulations for use in metered dose inhalers are disclosed which include 1,1,1,2-tetrafluoroethane alone and in combination with other compounds as well as various hydrocarbon blends. The density, vapor pressure, flame extension characteristics, dispersability of medicant, dissolvability of surfactant, respirable fraction, and compatibility elastomer seals for the aerosol formulations have been examined. The aerosol formulations are attractive alternatives to chlorofluorocarbon based aerosols since they do not deplete the ozone layer.
![Acyl and ester derivatives of 1,3-diazabicyclo[3,3,0]octane - US Patent 4584387 - Page 1](http://www.wikipatents.com/acyl-and-ester-derivatives-of-13-diazabicyclo330octane/T/US4584387-1.jpg "Acyl and ester derivatives of 1,3-diazabicyclo[3,3,0]octane - US Patent 4584387 - Page 1")
![Acyl and ester derivatives of 1,3-diazabicyclo[3,3,0]octane - US Patent 4584387 - Page 2](http://www.wikipatents.com/acyl-and-ester-derivatives-of-13-diazabicyclo330octane/T/US4584387-2.jpg "Acyl and ester derivatives of 1,3-diazabicyclo[3,3,0]octane - US Patent 4584387 - Page 2")
![Acyl and ester derivatives of 1,3-diazabicyclo[3,3,0]octane - US Patent 4584387 - Page 3](http://www.wikipatents.com/acyl-and-ester-derivatives-of-13-diazabicyclo330octane/T/US4584387-3.jpg "Acyl and ester derivatives of 1,3-diazabicyclo[3,3,0]octane - US Patent 4584387 - Page 3")
![Acyl and ester derivatives of 1,3-diazabicyclo[3,3,0]octane - US Patent 4584387 - Page 4](http://www.wikipatents.com/acyl-and-ester-derivatives-of-13-diazabicyclo330octane/T/US4584387-4.jpg "Acyl and ester derivatives of 1,3-diazabicyclo[3,3,0]octane - US Patent 4584387 - Page 4")
![Acyl and ester derivatives of 1,3-diazabicyclo[3,3,0]octane - US Patent 4584387 - Page 5](http://www.wikipatents.com/acyl-and-ester-derivatives-of-13-diazabicyclo330octane/T/US4584387-5.jpg "Acyl and ester derivatives of 1,3-diazabicyclo[3,3,0]octane - US Patent 4584387 - Page 5")
![Acyl and ester derivatives of 1,3-diazabicyclo[3,3,0]octane - US Patent 4584387 - Page 6](http://www.wikipatents.com/acyl-and-ester-derivatives-of-13-diazabicyclo330octane/T/US4584387-6.jpg "Acyl and ester derivatives of 1,3-diazabicyclo[3,3,0]octane - US Patent 4584387 - Page 6")
